- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Biologics and Biosimilars market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Biologics and Biosimilars market size is estimated to be worth US$ 198790 million in 2021 and is forecast to a readjusted size of USD 277500 million by 2028 with a CAGR of 4.9% during review period. Tumor accounting for % of the Biologics and Biosimilars global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Monoclonal Antibodies segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Biologics and Biosimilars include Roche, Amgen, AbbVie, Sanofi-Aventis, and Johnson & Johnson, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Biologics and Biosimilars market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Others
Market segment by Application can be divided into
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
The key market players for global Biologics and Biosimilars market are listed below:
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biologics and Biosimilars product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biologics and Biosimilars, with price, sales, revenue and global market share of Biologics and Biosimilars from 2019 to 2022.
Chapter 3, the Biologics and Biosimilars competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biologics and Biosimilars breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Biologics and Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biologics and Biosimilars.
Chapter 13, 14, and 15, to describe Biologics and Biosimilars sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Biologics and Biosimilars Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biologics and Biosimilars Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Monoclonal Antibodies
1.2.3 Interferon
1.2.4 Erythropoietin
1.2.5 Insulin
1.2.6 Vaccines
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Biologics and Biosimilars Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Others
1.4 Global Biologics and Biosimilars Market Size & Forecast
1.4.1 Global Biologics and Biosimilars Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Biologics and Biosimilars Sales in Volume (2017-2028)
1.4.3 Global Biologics and Biosimilars Price (2017-2028)
1.5 Global Biologics and Biosimilars Production Capacity Analysis
1.5.1 Global Biologics and Biosimilars Total Production Capacity (2017-2028)
1.5.2 Global Biologics and Biosimilars Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Biologics and Biosimilars Market Drivers
1.6.2 Biologics and Biosimilars Market Restraints
1.6.3 Biologics and Biosimilars Trends Analysis
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Biologics and Biosimilars Product and Services
2.1.4 Roche Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Biologics and Biosimilars Product and Services
2.2.4 Amgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business
2.3.3 AbbVie Biologics and Biosimilars Product and Services
2.3.4 AbbVie Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sanofi-Aventis
2.4.1 Sanofi-Aventis Details
2.4.2 Sanofi-Aventis Major Business
2.4.3 Sanofi-Aventis Biologics and Biosimilars Product and Services
2.4.4 Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Biologics and Biosimilars Product and Services
2.5.4 Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Biologics and Biosimilars Product and Services
2.6.4 Pfizer Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Novo Nordisk
2.7.1 Novo Nordisk Details
2.7.2 Novo Nordisk Major Business
2.7.3 Novo Nordisk Biologics and Biosimilars Product and Services
2.7.4 Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Eli Lilly
2.8.1 Eli Lilly Details
2.8.2 Eli Lilly Major Business
2.8.3 Eli Lilly Biologics and Biosimilars Product and Services
2.8.4 Eli Lilly Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business
2.9.3 Novartis Biologics and Biosimilars Product and Services
2.9.4 Novartis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Merck
2.10.1 Merck Details
2.10.2 Merck Major Business
2.10.3 Merck Biologics and Biosimilars Product and Services
2.10.4 Merck Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 3sbio
2.11.1 3sbio Details
2.11.2 3sbio Major Business
2.11.3 3sbio Biologics and Biosimilars Product and Services
2.11.4 3sbio Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Changchun High Tech
2.12.1 Changchun High Tech Details
2.12.2 Changchun High Tech Major Business
2.12.3 Changchun High Tech Biologics and Biosimilars Product and Services
2.12.4 Changchun High Tech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 CP Guojian
2.13.1 CP Guojian Details
2.13.2 CP Guojian Major Business
2.13.3 CP Guojian Biologics and Biosimilars Product and Services
2.13.4 CP Guojian Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Biotech
2.14.1 Biotech Details
2.14.2 Biotech Major Business
2.14.3 Biotech Biologics and Biosimilars Product and Services
2.14.4 Biotech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Gelgen
2.15.1 Gelgen Details
2.15.2 Gelgen Major Business
2.15.3 Gelgen Biologics and Biosimilars Product and Services
2.15.4 Gelgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Innovent
2.16.1 Innovent Details
2.16.2 Innovent Major Business
2.16.3 Innovent Biologics and Biosimilars Product and Services
2.16.4 Innovent Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Dong Bao
2.17.1 Dong Bao Details
2.17.2 Dong Bao Major Business
2.17.3 Dong Bao Biologics and Biosimilars Product and Services
2.17.4 Dong Bao Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Ganlee
2.18.1 Ganlee Details
2.18.2 Ganlee Major Business
2.18.3 Ganlee Biologics and Biosimilars Product and Services
2.18.4 Ganlee Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 United Laboratories
2.19.1 United Laboratories Details
2.19.2 United Laboratories Major Business
2.19.3 United Laboratories Biologics and Biosimilars Product and Services
2.19.4 United Laboratories Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Biologics and Biosimilars Breakdown Data by Manufacturer
3.1 Global Biologics and Biosimilars Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Biologics and Biosimilars Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Biologics and Biosimilars
3.4 Market Concentration Rate
3.4.1 Top 3 Biologics and Biosimilars Manufacturer Market Share in 2021
3.4.2 Top 6 Biologics and Biosimilars Manufacturer Market Share in 2021
3.5 Global Biologics and Biosimilars Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Biologics and Biosimilars Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Biologics and Biosimilars Market Size by Region
4.1.1 Global Biologics and Biosimilars Sales in Volume by Region (2017-2028)
4.1.2 Global Biologics and Biosimilars Revenue by Region (2017-2028)
4.2 North America Biologics and Biosimilars Revenue (2017-2028)
4.3 Europe Biologics and Biosimilars Revenue (2017-2028)
4.4 Asia-Pacific Biologics and Biosimilars Revenue (2017-2028)
4.5 South America Biologics and Biosimilars Revenue (2017-2028)
4.6 Middle East and Africa Biologics and Biosimilars Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Biologics and Biosimilars Sales in Volume by Type (2017-2028)
5.2 Global Biologics and Biosimilars Revenue by Type (2017-2028)
5.3 Global Biologics and Biosimilars Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Biologics and Biosimilars Sales in Volume by Application (2017-2028)
6.2 Global Biologics and Biosimilars Revenue by Application (2017-2028)
6.3 Global Biologics and Biosimilars Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Biologics and Biosimilars Sales by Type (2017-2028)
7.2 North America Biologics and Biosimilars Sales by Application (2017-2028)
7.3 North America Biologics and Biosimilars Market Size by Country
7.3.1 North America Biologics and Biosimilars Sales in Volume by Country (2017-2028)
7.3.2 North America Biologics and Biosimilars Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Biologics and Biosimilars Sales by Type (2017-2028)
8.2 Europe Biologics and Biosimilars Sales by Application (2017-2028)
8.3 Europe Biologics and Biosimilars Market Size by Country
8.3.1 Europe Biologics and Biosimilars Sales in Volume by Country (2017-2028)
8.3.2 Europe Biologics and Biosimilars Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Biologics and Biosimilars Sales by Type (2017-2028)
9.2 Asia-Pacific Biologics and Biosimilars Sales by Application (2017-2028)
9.3 Asia-Pacific Biologics and Biosimilars Market Size by Region
9.3.1 Asia-Pacific Biologics and Biosimilars Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Biologics and Biosimilars Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Biologics and Biosimilars Sales by Type (2017-2028)
10.2 South America Biologics and Biosimilars Sales by Application (2017-2028)
10.3 South America Biologics and Biosimilars Market Size by Country
10.3.1 South America Biologics and Biosimilars Sales in Volume by Country (2017-2028)
10.3.2 South America Biologics and Biosimilars Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Biologics and Biosimilars Sales by Type (2017-2028)
11.2 Middle East & Africa Biologics and Biosimilars Sales by Application (2017-2028)
11.3 Middle East & Africa Biologics and Biosimilars Market Size by Country
11.3.1 Middle East & Africa Biologics and Biosimilars Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Biologics and Biosimilars Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Biologics and Biosimilars and Key Manufacturers
12.2 Manufacturing Costs Percentage of Biologics and Biosimilars
12.3 Biologics and Biosimilars Production Process
12.4 Biologics and Biosimilars Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Biologics and Biosimilars Typical Distributors
13.3 Biologics and Biosimilars Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Biologics and Biosimilars Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Biologics and Biosimilars Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Biologics and Biosimilars Product and Services
Table 6. Roche Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Amgen Basic Information, Manufacturing Base and Competitors
Table 8. Amgen Major Business
Table 9. Amgen Biologics and Biosimilars Product and Services
Table 10. Amgen Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. AbbVie Basic Information, Manufacturing Base and Competitors
Table 12. AbbVie Major Business
Table 13. AbbVie Biologics and Biosimilars Product and Services
Table 14. AbbVie Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table 16. Sanofi-Aventis Major Business
Table 17. Sanofi-Aventis Biologics and Biosimilars Product and Services
Table 18. Sanofi-Aventis Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 20. Johnson & Johnson Major Business
Table 21. Johnson & Johnson Biologics and Biosimilars Product and Services
Table 22. Johnson & Johnson Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Biologics and Biosimilars Product and Services
Table 26. Pfizer Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 28. Novo Nordisk Major Business
Table 29. Novo Nordisk Biologics and Biosimilars Product and Services
Table 30. Novo Nordisk Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 32. Eli Lilly Major Business
Table 33. Eli Lilly Biologics and Biosimilars Product and Services
Table 34. Eli Lilly Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Novartis Basic Information, Manufacturing Base and Competitors
Table 36. Novartis Major Business
Table 37. Novartis Biologics and Biosimilars Product and Services
Table 38. Novartis Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Merck Basic Information, Manufacturing Base and Competitors
Table 40. Merck Major Business
Table 41. Merck Biologics and Biosimilars Product and Services
Table 42. Merck Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. 3sbio Basic Information, Manufacturing Base and Competitors
Table 44. 3sbio Major Business
Table 45. 3sbio Biologics and Biosimilars Product and Services
Table 46. 3sbio Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Changchun High Tech Basic Information, Manufacturing Base and Competitors
Table 48. Changchun High Tech Major Business
Table 49. Changchun High Tech Biologics and Biosimilars Product and Services
Table 50. Changchun High Tech Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. CP Guojian Basic Information, Manufacturing Base and Competitors
Table 52. CP Guojian Major Business
Table 53. CP Guojian Biologics and Biosimilars Product and Services
Table 54. CP Guojian Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Biotech Basic Information, Manufacturing Base and Competitors
Table 56. Biotech Major Business
Table 57. Biotech Biologics and Biosimilars Product and Services
Table 58. Biotech Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Gelgen Basic Information, Manufacturing Base and Competitors
Table 60. Gelgen Major Business
Table 61. Gelgen Biologics and Biosimilars Product and Services
Table 62. Gelgen Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Innovent Basic Information, Manufacturing Base and Competitors
Table 64. Innovent Major Business
Table 65. Innovent Biologics and Biosimilars Product and Services
Table 66. Innovent Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Dong Bao Basic Information, Manufacturing Base and Competitors
Table 68. Dong Bao Major Business
Table 69. Dong Bao Biologics and Biosimilars Product and Services
Table 70. Dong Bao Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Ganlee Basic Information, Manufacturing Base and Competitors
Table 72. Ganlee Major Business
Table 73. Ganlee Biologics and Biosimilars Product and Services
Table 74. Ganlee Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. United Laboratories Basic Information, Manufacturing Base and Competitors
Table 76. United Laboratories Major Business
Table 77. United Laboratories Biologics and Biosimilars Product and Services
Table 78. United Laboratories Biologics and Biosimilars Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Global Biologics and Biosimilars Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 80. Global Biologics and Biosimilars Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 81. Market Position of Manufacturers in Biologics and Biosimilars, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 82. Global Biologics and Biosimilars Production Capacity by Company, (K Units): 2020 VS 2021
Table 83. Head Office and Biologics and Biosimilars Production Site of Key Manufacturer
Table 84. Biologics and Biosimilars New Entrant and Capacity Expansion Plans
Table 85. Biologics and Biosimilars Mergers & Acquisitions in the Past Five Years
Table 86. Global Biologics and Biosimilars Sales by Region (2017-2022) & (K Units)
Table 87. Global Biologics and Biosimilars Sales by Region (2023-2028) & (K Units)
Table 88. Global Biologics and Biosimilars Revenue by Region (2017-2022) & (USD Million)
Table 89. Global Biologics and Biosimilars Revenue by Region (2023-2028) & (USD Million)
Table 90. Global Biologics and Biosimilars Sales by Type (2017-2022) & (K Units)
Table 91. Global Biologics and Biosimilars Sales by Type (2023-2028) & (K Units)
Table 92. Global Biologics and Biosimilars Revenue by Type (2017-2022) & (USD Million)
Table 93. Global Biologics and Biosimilars Revenue by Type (2023-2028) & (USD Million)
Table 94. Global Biologics and Biosimilars Price by Type (2017-2022) & (USD/Unit)
Table 95. Global Biologics and Biosimilars Price by Type (2023-2028) & (USD/Unit)
Table 96. Global Biologics and Biosimilars Sales by Application (2017-2022) & (K Units)
Table 97. Global Biologics and Biosimilars Sales by Application (2023-2028) & (K Units)
Table 98. Global Biologics and Biosimilars Revenue by Application (2017-2022) & (USD Million)
Table 99. Global Biologics and Biosimilars Revenue by Application (2023-2028) & (USD Million)
Table 100. Global Biologics and Biosimilars Price by Application (2017-2022) & (USD/Unit)
Table 101. Global Biologics and Biosimilars Price by Application (2023-2028) & (USD/Unit)
Table 102. North America Biologics and Biosimilars Sales by Country (2017-2022) & (K Units)
Table 103. North America Biologics and Biosimilars Sales by Country (2023-2028) & (K Units)
Table 104. North America Biologics and Biosimilars Revenue by Country (2017-2022) & (USD Million)
Table 105. North America Biologics and Biosimilars Revenue by Country (2023-2028) & (USD Million)
Table 106. North America Biologics and Biosimilars Sales by Type (2017-2022) & (K Units)
Table 107. North America Biologics and Biosimilars Sales by Type (2023-2028) & (K Units)
Table 108. North America Biologics and Biosimilars Sales by Application (2017-2022) & (K Units)
Table 109. North America Biologics and Biosimilars Sales by Application (2023-2028) & (K Units)
Table 110. Europe Biologics and Biosimilars Sales by Country (2017-2022) & (K Units)
Table 111. Europe Biologics and Biosimilars Sales by Country (2023-2028) & (K Units)
Table 112. Europe Biologics and Biosimilars Revenue by Country (2017-2022) & (USD Million)
Table 113. Europe Biologics and Biosimilars Revenue by Country (2023-2028) & (USD Million)
Table 114. Europe Biologics and Biosimilars Sales by Type (2017-2022) & (K Units)
Table 115. Europe Biologics and Biosimilars Sales by Type (2023-2028) & (K Units)
Table 116. Europe Biologics and Biosimilars Sales by Application (2017-2022) & (K Units)
Table 117. Europe Biologics and Biosimilars Sales by Application (2023-2028) & (K Units)
Table 118. Asia-Pacific Biologics and Biosimilars Sales by Region (2017-2022) & (K Units)
Table 119. Asia-Pacific Biologics and Biosimilars Sales by Region (2023-2028) & (K Units)
Table 120. Asia-Pacific Biologics and Biosimilars Revenue by Region (2017-2022) & (USD Million)
Table 121. Asia-Pacific Biologics and Biosimilars Revenue by Region (2023-2028) & (USD Million)
Table 122. Asia-Pacific Biologics and Biosimilars Sales by Type (2017-2022) & (K Units)
Table 123. Asia-Pacific Biologics and Biosimilars Sales by Type (2023-2028) & (K Units)
Table 124. Asia-Pacific Biologics and Biosimilars Sales by Application (2017-2022) & (K Units)
Table 125. Asia-Pacific Biologics and Biosimilars Sales by Application (2023-2028) & (K Units)
Table 126. South America Biologics and Biosimilars Sales by Country (2017-2022) & (K Units)
Table 127. South America Biologics and Biosimilars Sales by Country (2023-2028) & (K Units)
Table 128. South America Biologics and Biosimilars Revenue by Country (2017-2022) & (USD Million)
Table 129. South America Biologics and Biosimilars Revenue by Country (2023-2028) & (USD Million)
Table 130. South America Biologics and Biosimilars Sales by Type (2017-2022) & (K Units)
Table 131. South America Biologics and Biosimilars Sales by Type (2023-2028) & (K Units)
Table 132. South America Biologics and Biosimilars Sales by Application (2017-2022) & (K Units)
Table 133. South America Biologics and Biosimilars Sales by Application (2023-2028) & (K Units)
Table 134. Middle East & Africa Biologics and Biosimilars Sales by Region (2017-2022) & (K Units)
Table 135. Middle East & Africa Biologics and Biosimilars Sales by Region (2023-2028) & (K Units)
Table 136. Middle East & Africa Biologics and Biosimilars Revenue by Region (2017-2022) & (USD Million)
Table 137. Middle East & Africa Biologics and Biosimilars Revenue by Region (2023-2028) & (USD Million)
Table 138. Middle East & Africa Biologics and Biosimilars Sales by Type (2017-2022) & (K Units)
Table 139. Middle East & Africa Biologics and Biosimilars Sales by Type (2023-2028) & (K Units)
Table 140. Middle East & Africa Biologics and Biosimilars Sales by Application (2017-2022) & (K Units)
Table 141. Middle East & Africa Biologics and Biosimilars Sales by Application (2023-2028) & (K Units)
Table 142. Biologics and Biosimilars Raw Material
Table 143. Key Manufacturers of Biologics and Biosimilars Raw Materials
Table 144. Direct Channel Pros & Cons
Table 145. Indirect Channel Pros & Cons
Table 146. Biologics and Biosimilars Typical Distributors
Table 147. Biologics and Biosimilars Typical Customers
List of Figures
Figure 1. Biologics and Biosimilars Picture
Figure 2. Global Biologics and Biosimilars Revenue Market Share by Type in 2021
Figure 3. Monoclonal Antibodies
Figure 4. Interferon
Figure 5. Erythropoietin
Figure 6. Insulin
Figure 7. Vaccines
Figure 8. Others
Figure 9. Global Biologics and Biosimilars Revenue Market Share by Application in 2021
Figure 10. Tumor
Figure 11. Diabetes
Figure 12. Cardiovascular
Figure 13. Hemophilia
Figure 14. Others
Figure 15. Global Biologics and Biosimilars Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 16. Global Biologics and Biosimilars Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global Biologics and Biosimilars Sales (2017-2028) & (K Units)
Figure 18. Global Biologics and Biosimilars Price (2017-2028) & (USD/Unit)
Figure 19. Global Biologics and Biosimilars Production Capacity (2017-2028) & (K Units)
Figure 20. Global Biologics and Biosimilars Production Capacity by Geographic Region: 2022 VS 2028
Figure 21. Biologics and Biosimilars Market Drivers
Figure 22. Biologics and Biosimilars Market Restraints
Figure 23. Biologics and Biosimilars Market Trends
Figure 24. Global Biologics and Biosimilars Sales Market Share by Manufacturer in 2021
Figure 25. Global Biologics and Biosimilars Revenue Market Share by Manufacturer in 2021
Figure 26. Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 27. Top 3 Biologics and Biosimilars Manufacturer (Revenue) Market Share in 2021
Figure 28. Top 6 Biologics and Biosimilars Manufacturer (Revenue) Market Share in 2021
Figure 29. Global Biologics and Biosimilars Sales Market Share by Region (2017-2028)
Figure 30. Global Biologics and Biosimilars Revenue Market Share by Region (2017-2028)
Figure 31. North America Biologics and Biosimilars Revenue (2017-2028) & (USD Million)
Figure 32. Europe Biologics and Biosimilars Revenue (2017-2028) & (USD Million)
Figure 33. Asia-Pacific Biologics and Biosimilars Revenue (2017-2028) & (USD Million)
Figure 34. South America Biologics and Biosimilars Revenue (2017-2028) & (USD Million)
Figure 35. Middle East & Africa Biologics and Biosimilars Revenue (2017-2028) & (USD Million)
Figure 36. Global Biologics and Biosimilars Sales Market Share by Type (2017-2028)
Figure 37. Global Biologics and Biosimilars Revenue Market Share by Type (2017-2028)
Figure 38. Global Biologics and Biosimilars Price by Type (2017-2028) & (USD/Unit)
Figure 39. Global Biologics and Biosimilars Sales Market Share by Application (2017-2028)
Figure 40. Global Biologics and Biosimilars Revenue Market Share by Application (2017-2028)
Figure 41. Global Biologics and Biosimilars Price by Application (2017-2028) & (USD/Unit)
Figure 42. North America Biologics and Biosimilars Sales Market Share by Type (2017-2028)
Figure 43. North America Biologics and Biosimilars Sales Market Share by Application (2017-2028)
Figure 44. North America Biologics and Biosimilars Sales Market Share by Country (2017-2028)
Figure 45. North America Biologics and Biosimilars Revenue Market Share by Country (2017-2028)
Figure 46. United States Biologics and Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Biologics and Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Biologics and Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Biologics and Biosimilars Sales Market Share by Type (2017-2028)
Figure 50. Europe Biologics and Biosimilars Sales Market Share by Application (2017-2028)
Figure 51. Europe Biologics and Biosimilars Sales Market Share by Country (2017-2028)
Figure 52. Europe Biologics and Biosimilars Revenue Market Share by Country (2017-2028)
Figure 53. Germany Biologics and Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Biologics and Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Biologics and Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Biologics and Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Biologics and Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Biologics and Biosimilars Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Biologics and Biosimilars Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Biologics and Biosimilars Sales Market Share by Region (2017-2028)
Figure 61. Asia-Pacific Biologics and Biosimilars Revenue Market Share by Region (2017-2028)
Figure 62. China Biologics and Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Biologics and Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Korea Biologics and Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Biologics and Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Biologics and Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Biologics and Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Biologics and Biosimilars Sales Market Share by Type (2017-2028)
Figure 69. South America Biologics and Biosimilars Sales Market Share by Application (2017-2028)
Figure 70. South America Biologics and Biosimilars Sales Market Share by Country (2017-2028)
Figure 71. South America Biologics and Biosimilars Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Biologics and Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Biologics and Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East & Africa Biologics and Biosimilars Sales Market Share by Type (2017-2028)
Figure 75. Middle East & Africa Biologics and Biosimilars Sales Market Share by Application (2017-2028)
Figure 76. Middle East & Africa Biologics and Biosimilars Sales Market Share by Region (2017-2028)
Figure 77. Middle East & Africa Biologics and Biosimilars Revenue Market Share by Region (2017-2028)
Figure 78. Turkey Biologics and Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Egypt Biologics and Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Biologics and Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. South Africa Biologics and Biosimilars Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Manufacturing Cost Structure Analysis of Biologics and Biosimilars in 2021
Figure 83. Manufacturing Process Analysis of Biologics and Biosimilars
Figure 84. Biologics and Biosimilars Industrial Chain
Figure 85. Sales Channel: Direct Channel vs Indirect Channel
Figure 86. Methodology
Figure 87. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
